HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Philippe Lory Selected Research

T-Type Calcium Channels (T-Type Calcium Channel)

2/2016Blockade of T-type calcium channels prevents tonic-clonic seizures in a maximal electroshock seizure model.
11/2015A Recurrent Mutation in CACNA1G Alters Cav3.1 T-Type Calcium-Channel Conduction and Causes Autosomal-Dominant Cerebellar Ataxia.
2/2014Cross-modulation and molecular interaction at the Cav3.3 protein between the endogenous lipids and the T-type calcium channel antagonist TTA-A2.
7/2008T-type calcium channels: from discovery to channelopathies, 25 years of research.
5/2007Mutational analysis of CACNA1G in idiopathic generalized epilepsy. Mutation in brief #962. Online.
8/2006Molecular pathways underlying the modulation of T-type calcium channels by neurotransmitters and hormones.
6/2006Bradycardia and slowing of the atrioventricular conduction in mice lacking CaV3.1/alpha1G T-type calcium channels.
4/2006A role for voltage gated T-type calcium channels in mediating "capacitative" calcium entry?
8/2002Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Philippe Lory Research Topics

Disease

7Channelopathies
11/2015 - 11/2006
4Epilepsy (Aura)
02/2014 - 05/2007
3Type 2 Episodic Ataxia
10/2017 - 07/2010
3Seizures (Absence Seizure)
02/2016 - 07/2010
3Neoplasms (Cancer)
02/2014 - 04/2006
2Episodic Ataxia
08/2014 - 04/2008
2Nervous System Diseases (Neurological Disorders)
08/2014 - 07/2010
2Generalized Epilepsy
07/2010 - 05/2007
2Absence Epilepsy (Childhood Absence Epilepsy)
07/2010 - 08/2006
2Neuroblastoma
03/2004 - 08/2002
1Paralysis (Palsy)
01/2021
1Myotonic Disorders (Paramyotonia Congenita)
01/2021
1Mucopolysaccharidosis VII (Sly Syndrome)
11/2018
1Lysosomal Storage Diseases (Lysosomal Storage Disease)
11/2018
1Atrophy
01/2018
1Familial Hyperaldosteronism
11/2016
1Adenoma (Adenomas)
11/2016
1Pain (Aches)
01/2016
1Cerebellar Ataxia (Dysmetria)
11/2015
1Ataxia (Dyssynergia)
08/2014
1Motor Disorders
08/2014
1Hypertension (High Blood Pressure)
02/2014
1Sleep Wake Disorders
02/2014
1Heart Diseases (Heart Disease)
01/2014
1Bipolar Disorder (Manic Depressive Psychosis)
01/2014
1Autistic Disorder (Autism)
01/2014
1Alzheimer Disease (Alzheimer's Disease)
01/2014
1Alcoholism (Alcohol Abuse)
01/2014
1Schizophrenia (Dementia Praecox)
01/2014
1Autism Spectrum Disorder
07/2010
1Migraine with Aura (Familial Hemiplegic Migraine)
07/2010
1Spinocerebellar Ataxias (Spinocerebellar Ataxia)
07/2010
1Inborn Genetic Diseases (Disease, Hereditary)
11/2006
1Bradycardia
06/2006

Drug/Important Bio-Agent (IBA)

9T-Type Calcium Channels (T-Type Calcium Channel)IBA
02/2016 - 08/2002
8CalciumIBA
11/2015 - 03/2004
7Calcium Channels (Calcium Channel)IBA
01/2018 - 03/2004
4Q-Type Calcium Channels (Q-Type Calcium Channel)IBA
10/2017 - 04/2008
4voltage-dependent calcium channel (P-Q type)IBA
10/2017 - 04/2008
2Carbonic Anhydrase InhibitorsIBA
01/2021 - 08/2014
1GlucuronidaseIBA
11/2018
1AldosteroneIBA
11/2016
12- (4- cyclopropylphenyl)- N- (1- (5- ((2,2,2- trifluoroethyl)oxo)pyridin- 2- yl)ethyl)acetamideIBA
02/2016
1Mitogen-Activated Protein Kinase 3IBA
02/2016
1Mechanistic Target of Rapamycin Complex 1IBA
12/2015
1Adrenergic Agents (Adrenergic Drugs)IBA
08/2014
1Acetazolamide (Diamox)FDA LinkGeneric
08/2014
1Proteins (Proteins, Gene)FDA Link
01/2014
1L-Type Calcium Channels (Dihydropyridine Receptor)IBA
12/2011
1Ligand-Gated Ion ChannelsIBA
07/2010
1Pharmaceutical PreparationsIBA
07/2010
1Immunoglobulin E (IgE)IBA
05/2007
1Protein Subunits (Protein Subunit)IBA
11/2006
1Adenosine Triphosphate (ATP)IBA
04/2006
1MibefradilIBA
04/2006
1ThapsigarginIBA
04/2006